{ "items": [ "\n\n
\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n COMRU\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n20 December 2021
\n \n \n \nIn the 2021 Oxford Recognition of Distinction round, four MORU colleagues were awarded Full Professor title.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n24 November 2021
\n \n \n \nFeatured in Nature, Victor Chaumeau collects mosquitoes in Myanmar to better understand how to control malaria.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n24 November 2021
\n \n \n \nPatients in north Africa and the Middle East are using antibiotics in sharply rising quantities far beyond the global average, raising concerns over the escalating risks of resistance to medicines to treat bacterial infections. Estimated antibiotic consumption for 204 countries between 2000 and 2018 shows a 46 per cent increase in global antibiotic usage, with a surge in nations including India and Vietnam.
\n \n\n \n \n\n \n\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n19 November 2021
\n \n \n \nA downloadable resource for educators, health & research professionals to help develop young peoples\u2019 understanding of AMR and positive actions they can take to mitigate it.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n18 November 2021
\n \n \n \nTo mark WHO World Antimicrobial Awareness Week, 18-24 Nov 2021, and help reduce the overuse of antibiotics, MORU researchers have released a new, easy to use online tool \u2013 Antibiotic Footprint Calculator \u2013 that could make an important contribution in the fight against antimicrobial resistance (AMR), one of the world\u2019s most significant emerging threats to public health.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n12 November 2021
\n \n \n \nGlobal antibiotic consumption rates increased by 46 percent in the last two decades, according to the first study to provide longitudinal estimates for human antibiotic consumption covering 204 countries from 2000 to 2018, published in Lancet Planetary Health by the Global Research on Antimicrobial Resistance (GRAM) Project.
\n \n\n \n \n\n \n\n \n \n \n \n LOMWRU\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n11 October 2021
\n \n \n \nA series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n22 September 2021
\n \n \n \nEvery year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (NDM-CGHR) as second year DPhil student. Our warmest congratulations to you all!
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n21 September 2021
\n \n \n \nThere are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n14 September 2021
\n \n \n \nFollowing the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n30 July 2021
\n \n \n \nA 6-week recruitment burst at Aga Khan University in Pakistan led the way as COPCOV enrolment broke 1600 participants. Led by MORU, COPCOV is the world\u2019s largest trial trying to determine if hydroxychloroquine and chloroquine prevent COVID-19.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n21 July 2021
\n \n \n \nAn international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues report the unequal impacts of public health measures, and the prevalence of \u2018fake news\u2019.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n9 July 2021
\n \n \n \nAs high COVID-19 daily cases and highly transmissible variants risk overwhelming countries\u2019 healthcare systems, COPCOV, the world\u2019s last-standing large prophylaxis RCT, faces tight timelines to determine whether chloroquine/ hydroxychloroquine prevents COVID-19
\n \n\n \n \n\n \n\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n8 July 2021
\n \n \n \nAbout one-third of children diagnosed with severe malaria may instead have an alternative cause of illness, but simple blood tests could help researchers distinguish between the two and speed up research on new treatments.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n8 June 2021
\n \n \n \nMalaria continues to be a major killer, particularly in sub-Saharan Africa, affecting the world\u2019s most vulnerable populations with more than 500,000 deaths per year, most of them African children. Emergence of resistance to antimalarial drugs is major public health issue. American Society for Microbiology Editor Dr Cesar Arias discusses with Professor Sir Nick White the latest information on this rapidly evolving field.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n19 May 2021
\n \n \n \nWhich infections are most common in the Chiangrai region? How should we treat them and how can we improve diagnostic? Which strategies are most effective in directing antibiotic treatment? Blog by Carlo Perrone, research physician based at the Chiang Rai Clinical Research Unit in Chiangrai, Thailand.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n\n \n\n\n
\n \n\n \n12 May 2021
\n \n \n \n\"Although it is hard to look beyond the pandemic right now,\" says President of the Academy of Medical Sciences Professor Dame Anne Johnson, \"I want to stress how important it is that the Academy Fellowship represents the widest diversity of biomedical and health sciences. The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration.\"
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n7 May 2021
\n \n \n \nLive and on-line from Bangkok! Be ready for Thursday 13th May, when Pint of Science Thailand will stream live from Bangkok. Join us via Facebook, YouTube or right here from the Pint of Science Thailand website as we journey from bacterial infections to viruses, discover how clinical trials work, and how scientific development is seen in the eyes of the law!
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n25 April 2021
\n \n \n \nFor World Malaria Day 2021, F1000 Research Blog spoke to Professor Phaik Yeong Cheah about her research focussed on drama and arts-based community engagement for malaria research, published with Wellcome Open Research.
\n \n\n \n \n\n \n\n \n \n \n \n MORU\n \n \n\n \n\n\n
\n \n\n \n23 April 2021
\n \n \n \nOn Sunday 25 April, World Malaria Day, the Developing Paediatric Primaquine (DPP) project will launch its website. DPP will produce children-appropriate primaquine doses that could both cut malaria deaths in vulnerable African children by blocking transmission of P. falciparum malaria and reduce P. vivax malaria more widely.
\n \n\n \n \n